Author

Can Yilgor

Terasaki FoundationORCID 0009-0000-9214-4324Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Ali KhademhosseiniiD· 2 shared Christopher Jewell· 2 shared Danial KhorsandiiD· 2 shared Mehmet R. DokmeciiD· 2 shared Satoru KawakitaiD· 2 shared Surjendu MaityiD· 2 shared Vadim JucaudiD· 2 shared Alejandro Gomez· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Ali KhademhosseiniORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCell ReportsPeer-reviewedJan 1, 2026

Human Organoid Tumor Transplantation Identifies Functional Glioblastoma - Microenvironmental Communication Mediated by PTPRZ1

Weihong Ge, Ryan L. Kan, Can Yilgor…·Aparna Bhaduri

The paper uses a human organoid tumor transplantation system to study glioblastoma-microenvironment interactions, identifying PTPRZ1 as a key mediator of intercellular communication.

17 citationstop 1%

humanorganoid / primary culture

𝕏 PostBluesky

BioengineeringActa BiomaterialiaPeer-reviewedMay 16, 2025

Microphysiological system modeling pericyte-induced temozolomide resistance in glioblastoma

Surjendu Maity, Christopher Jewell, Can Yilgor…·Vadim Jucaud

This paper develops a 3D GBM model with pericytes to study TMZ resistance, finding that pericytes increase TMZ resistance in GBM spheroids by upregulating CCL5.

11 citationstop 4%

humanexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintMay 14, 2025

Modeling Immunosenescence on-a-chip: a platform for cancer vaccine efficacy assessment

Surjendu Maity, Alireza Hassani Najafabadi, Satoru Kawakita…·Vadim Jucaud

The paper develops an in vitro platform to assess cancer vaccine efficacy in aging immune systems, showing age-dependent differences in antigen presentation and T cell responses.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky